Bioiberica announces results of new study demonstrating benefits of its hyaluronic acid matrix ingredient

Photo © Shutterstock.com/goodluz

Bioiberica (Barcelona, Spain) has announced the results of a new clinical trial investigating the effects of its Dermial hyaluronic acid matrix ingredient. The results of the study, which show that Dermial may support skin hydration, reduce wrinkles, and increase skin brightness, will be presented at the Annual Meeting of the Society for Investigative Dermatology (SID) in Dallas, TX, and Bioiberica’s team will also be available to discuss the study at Vitafoods Europe (booth F142), both of which are taking place this week.

In the study, 60 women between the ages of 35 and 65 were randomized to receive either 60 mg of Dermial or placebo daily for 12 weeks. According to Bioiberica, the results showed that Dermial supplementation was associated with a 20% increase in skin brightness after six weeks, and 34% increase in skin brightness after 12 weeks. There was also a statistically significant difference in wrinkle reduction compared to placebo, as well as significant improvements in hydration of the stratum corneum (the outermost layer of the epidermis), scaliness (dryness), Tª (skin temperature) and erythema index (redness of skin) in the Dermial group, compared to baseline.

“Taken together, these results confirm that a low daily dose of Dermial is safe and supports the homeostasis, appearance and integrity of ageing skin,” said Daniel Martínez-Puig, head of R&D Human and Animal Health at Bioiberica and one of the trial’s investigators, in a press release. “But that’s not all. We also assessed satisfaction scores in both groups. Consumer satisfaction was significantly higher in supplemented women (69%) compared to placebo (42%), indicating that they experienced tangible benefits when using Dermial.”

“This is an exciting time for innovation in the nutricosmetics space,” added Antonio Vendrell, marketing director at Bioiberica. “There is ever-growing demand for beauty-from-within solutions, from consumers of all demographics and backgrounds – and the market craves science-backed and convenient solutions. We’re therefore extremely excited to share this latest compelling evidence from our clinical trial and soaring consumer satisfaction scores, as it gives our partners confidence that, once they’ve experienced Dermial, consumers will be back for more.”

The study is awaiting publication.